share_log

復星醫藥:非登記股東之通知信函及申請表格

FOSUN PHARMA: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

Hong Kong Stock Exchange ·  Apr 24 04:49
Summary by Moomoo AI
上海復星醫藥(集團)股份有限公司於2024年4月24日向非登記H股股東發出通知,公告其2023年年報已可在公司及香港聯合交易所有限公司網站上獲得。股東若需印刷版年報,可填妥申請表格並透過郵件或電子郵件方式回傳給H股股份過戶登記處卓佳證券登記有限公司。公司提供了詳細的聯絡資訊及申請指南,以便股東能夠方便地索取相關文件。
上海復星醫藥(集團)股份有限公司於2024年4月24日向非登記H股股東發出通知,公告其2023年年報已可在公司及香港聯合交易所有限公司網站上獲得。股東若需印刷版年報,可填妥申請表格並透過郵件或電子郵件方式回傳給H股股份過戶登記處卓佳證券登記有限公司。公司提供了詳細的聯絡資訊及申請指南,以便股東能夠方便地索取相關文件。
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. ISSUED A NOTICE ON 24 APRIL 2024 TO NON-REGISTERED H SHAREHOLDERS ANNOUNCING THAT ITS 2023 ANNUAL REPORT IS AVAILABLE ON THE COMPANY'S WEBSITE AND ON THE HKEX LIMITED WEBSITE. If shareholders require a printed annual report, they may complete the application form and send it back to the H Share Transfer Registry, Chujia Securities Registry Limited by mail or e-mail. The Company provides detailed contact information and application guidance so that shareholders can easily request relevant documents.
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. ISSUED A NOTICE ON 24 APRIL 2024 TO NON-REGISTERED H SHAREHOLDERS ANNOUNCING THAT ITS 2023 ANNUAL REPORT IS AVAILABLE ON THE COMPANY'S WEBSITE AND ON THE HKEX LIMITED WEBSITE. If shareholders require a printed annual report, they may complete the application form and send it back to the H Share Transfer Registry, Chujia Securities Registry Limited by mail or e-mail. The Company provides detailed contact information and application guidance so that shareholders can easily request relevant documents.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more